← Landscape

Trial NCT07112287

Germline Testing for Predisposition to Myeloid Malignancies

Phase
Not given
Sponsor
Christopher Reilly
Conditions
Myeloid Malignancy; Genetic Predisposition to Disease; Myeloid Hematological Malignancies
Ages
18+ years
View on ClinicalTrials.gov ↗

Eligibility criteria

Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).

Inclusion Criteria: * Age of 18 years or older * Participants must have histologically confirmed myeloid malignancy OR bone marrow failure within the last 6 months prior to screening. * Ability to understand and provide a signed and completed consent document in English.Language Exclusion Criteria: * Participants who cannot safely undergo clinically indicated skin biopsy as adjudicated by the study team. * Participants who have previously undergone germline genetic testing for predisposition to myeloid malignancies

Restrictions found (1)

Recruiting in Massachusetts

  • Dana-Farber Cancer Institute · Boston, Suffolk County